TY - JOUR
T1 - Dynamic, Helminth-Induced Immune Modulation Influences the Outcome of Acute and Chronic Hepatitis B Virus Infection
AU - Loffredo-Verde, Eva
AU - Bhattacharjee, Sonakshi
AU - Malo, Antje
AU - Festag, Julia
AU - Kosinska, Anna D.
AU - Ringelhan, Marc
AU - Rim Sarkar, Sabrina
AU - Steiger, Katja
AU - Heikenwaelder, Mathias
AU - Protzer, Ulrike
AU - Da Costa, Clarissa U.Prazeres
N1 - Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
PY - 2020/4/7
Y1 - 2020/4/7
N2 - Background: Chronic hepatitis B develops more frequently in countries with high prevalence of helminth infections. The crosstalk between these 2 major liver-residing pathogens, Schistosoma mansoni and hepatitis B virus (HBV), is barely understood. Methods: We used state-of-the-art models for both acute and chronic HBV infection to study the pathogen-crosstalk during the different immune phases of schistosome infection. Results: Although liver pathology caused by schistosome infection was not affected by either acute or chronic HBV infection, S mansoni infection influenced HBV infection outcomes in a phase-dependent manner. Interferon (IFN)-γsecreting, HBV- and schistosome-specific CD8 T cells acted in synergy to reduce HBV-induced pathology during the TH1 phase and chronic phase of schistosomiasis. Consequently, HBV was completely rescued in IFN-γ-deficient or in TH2 phase coinfected mice demonstrating the key role of this cytokine. It is interesting to note that secondary helminth infection on the basis of persistent (chronic) HBV infection increased HBV-specific T-cell frequency and resulted in suppression of virus replication but failed to fully restore T-cell function and eliminate HBV. Conclusions: Thus, schistosome-induced IFN-γhad a prominent antiviral effect that outcompeted immunosuppressive effects of TH2 cytokines, whereas HBV coinfection did not alter schistosome pathogenicity.
AB - Background: Chronic hepatitis B develops more frequently in countries with high prevalence of helminth infections. The crosstalk between these 2 major liver-residing pathogens, Schistosoma mansoni and hepatitis B virus (HBV), is barely understood. Methods: We used state-of-the-art models for both acute and chronic HBV infection to study the pathogen-crosstalk during the different immune phases of schistosome infection. Results: Although liver pathology caused by schistosome infection was not affected by either acute or chronic HBV infection, S mansoni infection influenced HBV infection outcomes in a phase-dependent manner. Interferon (IFN)-γsecreting, HBV- and schistosome-specific CD8 T cells acted in synergy to reduce HBV-induced pathology during the TH1 phase and chronic phase of schistosomiasis. Consequently, HBV was completely rescued in IFN-γ-deficient or in TH2 phase coinfected mice demonstrating the key role of this cytokine. It is interesting to note that secondary helminth infection on the basis of persistent (chronic) HBV infection increased HBV-specific T-cell frequency and resulted in suppression of virus replication but failed to fully restore T-cell function and eliminate HBV. Conclusions: Thus, schistosome-induced IFN-γhad a prominent antiviral effect that outcompeted immunosuppressive effects of TH2 cytokines, whereas HBV coinfection did not alter schistosome pathogenicity.
KW - Coinfection
KW - Hepatitis B
KW - Immunomodulation
KW - Liver
KW - Schistosoma mansoni
UR - http://www.scopus.com/inward/record.url?scp=85083881306&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiz594
DO - 10.1093/infdis/jiz594
M3 - Article
C2 - 31875228
AN - SCOPUS:85083881306
SN - 0022-1899
VL - 221
SP - 1448
EP - 1461
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 9
ER -